Wall Street analysts expect athenahealth, Inc. (NASDAQ:ATHN) to report sales of $323.07 million for the current quarter, according to Zacks Investment Research. Twenty One analysts have provided estimates for athenahealth’s earnings. The highest sales estimate is $337.30 million and the lowest is $313.50 million. athenahealth posted sales of $288.20 million during the same quarter last year, which would indicate a positive year over year growth rate of 12.1%. The firm is expected to announce its next earnings report on Thursday, February 1st.

According to Zacks, analysts expect that athenahealth will report full year sales of $323.07 million for the current year, with estimates ranging from $1.20 billion to $1.24 billion. For the next financial year, analysts forecast that the business will report sales of $1.36 billion per share, with estimates ranging from $1.31 billion to $1.42 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that cover athenahealth.

athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.06. The business had revenue of $304.60 million for the quarter, compared to analyst estimates of $310.52 million. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. athenahealth’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.60 EPS.

Several research analysts have weighed in on ATHN shares. Oppenheimer reaffirmed a “buy” rating and set a $184.00 price target on shares of athenahealth in a research report on Friday, October 20th. Robert W. Baird reaffirmed a “buy” rating and set a $170.00 price target on shares of athenahealth in a research report on Thursday, August 31st. Piper Jaffray Companies reiterated a “buy” rating and set a $167.00 target price on shares of athenahealth in a research note on Tuesday, October 17th. KeyCorp reiterated a “buy” rating and set a $170.00 target price on shares of athenahealth in a research note on Sunday, September 17th. Finally, SunTrust Banks reiterated a “buy” rating and set a $156.00 target price on shares of athenahealth in a research note on Wednesday, October 25th. Two investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and eleven have assigned a buy rating to the company’s stock. athenahealth presently has a consensus rating of “Hold” and a consensus target price of $143.29.

athenahealth (NASDAQ ATHN) opened at $133.80 on Friday. The firm has a market capitalization of $5,291.14, a P/E ratio of 112.05, a price-to-earnings-growth ratio of 4.88 and a beta of 1.57. athenahealth has a 1 year low of $95.01 and a 1 year high of $158.66. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.67 and a current ratio of 1.67.

In related news, CEO Jonathan Bush sold 4,000 shares of the business’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $124.17, for a total value of $496,680.00. Following the completion of the sale, the chief executive officer now directly owns 319,807 shares in the company, valued at approximately $39,710,435.19. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Daniel P. Haley sold 1,583 shares of the business’s stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $124.56, for a total value of $197,178.48. Following the completion of the sale, the insider now owns 13,408 shares of the company’s stock, valued at $1,670,100.48. The disclosure for this sale can be found here. Insiders sold a total of 8,983 shares of company stock valued at $1,136,794 over the last 90 days. 3.20% of the stock is currently owned by corporate insiders.

Several large investors have recently added to or reduced their stakes in the company. Pura Vida Investments LLC lifted its position in shares of athenahealth by 39.1% during the 3rd quarter. Pura Vida Investments LLC now owns 59,800 shares of the health services provider’s stock valued at $7,437,000 after acquiring an additional 16,800 shares during the period. California Public Employees Retirement System lifted its position in shares of athenahealth by 1.6% during the 3rd quarter. California Public Employees Retirement System now owns 75,000 shares of the health services provider’s stock valued at $9,327,000 after acquiring an additional 1,200 shares during the period. Perceptive Advisors LLC bought a new stake in shares of athenahealth during the 3rd quarter valued at $8,705,000. Oppenheimer Asset Management Inc. lifted its position in shares of athenahealth by 2.4% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 31,974 shares of the health services provider’s stock valued at $3,977,000 after acquiring an additional 737 shares during the period. Finally, Jackson Square Partners LLC lifted its position in shares of athenahealth by 55.4% during the 3rd quarter. Jackson Square Partners LLC now owns 525,738 shares of the health services provider’s stock valued at $65,380,000 after acquiring an additional 187,491 shares during the period.

TRADEMARK VIOLATION NOTICE: “Zacks: Brokerages Anticipate athenahealth, Inc. (ATHN) Will Post Quarterly Sales of $323.07 Million” was originally published by American Banking News and is the property of of American Banking News. If you are reading this piece on another website, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/12/15/zacks-brokerages-anticipate-athenahealth-inc-athn-will-post-quarterly-sales-of-323-07-million.html.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Get a free copy of the Zacks research report on athenahealth (ATHN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.